Swiss-based Arpida is the latest biotech to announce a layoff. 60 employees will get the ax as a consequence of the negative FDA panel decision on the antibiotic Iclaprim. <a href="http://biz.yahoo.com/prnews/081127/ukth024.html" target="_blank">http://biz.yahoo.com/prnews/081127/ukth024.html</a>